The global burden of trachoma: a review.

PLoS Neglected Tropical Diseases
Matthew J Burton, David C Mabey

Abstract

Trachoma is the commonest infectious cause of blindness worldwide. Recurrent infection of the ocular surface by Chlamydia trachomatis, the causative agent, leads to inturning of the eyelashes (trichiasis) and blinding corneal opacification. Trachoma is endemic in more than 50 countries. It is currently estimated that there are about 1.3 million people blind from the disease and a further 8.2 million have trichiasis. Several estimates for the burden of disease from trachoma have been made, giving quite variable results. The variation is partly because different prevalence data have been used and partly because different sequelae have been included. The most recent estimate from the WHO placed it at around 1.3 million Disability-Adjusted Life Years (DALYs). A key issue in producing a reliable estimate of the global burden of trachoma is the limited amount of reliable survey data from endemic regions.

Citations

Nov 12, 2013·Trends in Plant Science·Agathe SubtilMatthias Horn
Jan 25, 2014·Genome Announcements·Vítor BorgesJoão P Gomes
May 29, 2014·Emerging Infectious Diseases·Stephen E SchachterleDavid J Sullivan
Apr 30, 2010·Bulletin of the World Health Organization·Maggie A Montgomery, Jamie Bartram
Sep 24, 2010·Future Microbiology·Kelsi M Sandoz, Daniel D Rockey
Sep 28, 2010·Journal of Bacteriology·Aishwarya V Ramaswamy, Anthony T Maurelli
Nov 3, 2010·BMC Medicine·Yaobi ZhangShawn Baker
Mar 14, 2012·PLoS Neglected Tropical Diseases·Hebe GoudaJeremiah Ngondi
Jul 21, 2012·Global Public Health·Josh Ruxin, Joel Negin
Jul 28, 2011·The Journal of Infectious Diseases·Isao MiyairiGerald I Byrne
Jan 5, 2012·International Ophthalmology·Khawla Abu Samra, Faris Azzouni
Nov 13, 2014·BMC Infectious Diseases·Mette T ChristiansenJudith Breuer
Feb 6, 2016·Journal of Medicinal Chemistry·James A D GoodFredrik Almqvist
Aug 30, 2011·Medical Hypotheses·Evan Hermel, Kevin D Klapstein
Apr 5, 2012·International Journal of Immunogenetics·M YavariE Hermel
Apr 9, 2010·Tropical Medicine & International Health : TM & IH·Victor H HuDavid C W Mabey
May 7, 2015·Biochemical and Biophysical Research Communications·Jeffrey MitalTed Hackstadt
Sep 8, 2010·Annals of Tropical Medicine and Parasitology·P CourtrightS Lewallen
Jun 2, 2015·Frontiers in Immunology·Sudhanshu ShekharXi Yang
Sep 26, 2012·Acta Tropica·Bruce H Noden, Berta E van der Colf
Jan 6, 2011·FEMS Immunology and Medical Microbiology·Brigida Rusconi, Gilbert Greub
Aug 10, 2012·PLoS Pathogens·Allan L ChenMing Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Tropical Medicine & International Health : TM & IH
Victor H HuDavid C Mabey
Proceedings of the National Academy of Sciences of the United States of America
Reynaldo A CarabeoT Hackstadt
Current Opinion in Infectious Diseases
John A White
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
D S A Beeckman, D C G Vanrompay
© 2022 Meta ULC. All rights reserved